Article Text

PDF
Observational study
Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers
  1. Karsten Juhl Jørgensen
  1. Rigshospitalet, Department 3343, The Nordic Cochrane Centre, Copenhagen, Denmark
  1. Correspondence to:Karsten Juhl Jørgensen
    , Rigshospitalet, Department 3343, The Nordic Cochrane Centre, Blegdamsvej 9, Copenhagen 2100, Denmark, kj{at}cochrane.dk

Statistics from Altmetric.com

Commentary on: Kalager M, Adami HO, Bretthauer M, et al. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 2012;156:491–9.

Context

There is no question that breast cancer screening identifies cancers that would never have surfaced in a woman's lifetime in the absence of screening (overdiagnosis). However, high-quality studies are needed to quantify this harm, and this is the main objective of the study by Kalager and colleagues. A review of incidence trends of breast cancers over 20 mm in size (which are by definition considered to be advanced) in seven countries with long-running breast screening found unchanged rates with screening.1 This suggests that the massive increases in early invasive breast cancers and in situ cases seen when breast screening is introduced does not prevent late-stage cancers and is therefore not early detection, but overdiagnosis. It also explains …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.